Furthermore, it is worth mentioning that, as recently demonstrated, COVID-19 patients who presented xerostomia presented lower salivary IL-2 levels, and the authors suggested that this reduction could be related to the direct damage of SARS-CoV-2 infection on the lymphocytes sited in the salivary glands [30]. This evidence concerns the gene IL2 and xerostomia.